Skip to main content

Table 1 Baseline demographic and clinical characteristics of patients

From: The predictive value of PaO2/FIO2 and additional parameters for in-hospital mortality in patients with acute pulmonary embolism: an 8-year prospective observational single-center cohort study

 

Survivors (n = 337, 91.6%)

Non-Survivors (n = 31, 8.4%)

Total (n = 368)

P-value

Male sex, n (%)

162 (48.1)

17 (54.8)

179 (48.6)

0.471

Age, years

75 (64–83)

79 (69–84)

76 (65–83)

0.096

BMI, kg/m2

24.4 (22–27)

21.2 (20.2–23.5)

24.2 (21.9–26.7)

0.000*

Medical history, n (%)

Hypertension

172 (51.0)

17 (54.8)

189 (51.3)

0.686

Coronary heart disease

65 (19.2)

9 (29.0)

74 (20.1)

0.196

Heart failure

18 (5.3)

2 (6.4)

20 (5.4)

0.794

COPD

20 (5.9)

4 (12.9)

24 (6.5)

0.133

Diabetes mellitus

58 (17.2)

8 (25.8)

64 (17.3)

0.233

Chronic liver disease

2 (0.5)

1 (3.2)

3 (0.8)

0.119

Chronic renal disease

16 (4.7)

3 (9.6)

19 (5.2)

0.236

Predisposing factors, n (%)

History of CVA

30 (8.9)

3 (9.6)

33 (9.0)

0.885

History of cancer

41 (12.1)

11 (35.5)

52 (14.1)

0.000*

Recent surgery

104 (30.8)

13 (41.9)

117 (31.8)

0.206

Immobilization >3 days

208 (61.7)

23 (74.2)

231 (62.8)

0.170

Varicosity

30 (8.9)

2 (6.5)

32 (8.7)

0.640

History of DVT

42 (12.4)

2 (6.5)

44 (12.0)

0.322

History of PE

51 (15.1)

3 (9.6)

54 (14.7)

0.409

History of trauma

22 (6.5)

1 (3.2)

23 (6.3)

0.466

Smokers

64 (19.0)

7 (22.5)

71 (19.3)

0.346

  1. BMI Body mass index, COPD Chronic obstructive pulmonary disease, CVA Cerebral vascular accident, DVT Deep vein thrombosis, PE Pulmonary thromboembolism